πŸ‡ΊπŸ‡Έ FDA
Patent

US 12059477

Nanomaterials

granted A61KA61K31/7105A61K31/711

Quick answer

US patent 12059477 (Nanomaterials) held by Beam Therapeutics Inc. expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beam Therapeutics Inc.
Grant date
Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/7105, A61K31/711, A61K47/24, A61K47/26